Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

0.2982
-0.0258-7.96%
Volume:189.15K
Turnover:56.98K
Market Cap:61.43M
PE:-0.05
High:0.3250
Open:0.3250
Low:0.2950
Close:0.3240
Loading ...

Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar

THOMSON REUTERS
·
03 Jan

Cyclacel Pharmaceuticals Exploring Alternatives, Cuts Costs to Preserve Cash

Dow Jones
·
06 Dec 2024

BRIEF-Cyclacel Pharmaceuticals Announces Its Exploration Of Potential Strategic Alternatives

Reuters
·
06 Dec 2024

Cyclacel Pharmaceuticals Inc - Exploring Strategic Alternatives

THOMSON REUTERS
·
06 Dec 2024

Cyclacel Pharmaceuticals Inc - Board Directs Management to Reduce Operating Costs

THOMSON REUTERS
·
06 Dec 2024

Cyclacel Pharmaceuticals- May Cease Operations IF No Strategic Transaction or Funding Is Secured

THOMSON REUTERS
·
06 Dec 2024

Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs

THOMSON REUTERS
·
06 Dec 2024

Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
15 Nov 2024

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

THOMSON REUTERS
·
14 Nov 2024

Cyclacel Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss

Zacks
·
13 Nov 2024

Cyclacel Pharmaceuticals Q3 2024 GAAP EPS $(0.18) Beats $(0.56) Estimate, Sales $10.000K Beat $5.000K Estimate

Benzinga
·
13 Nov 2024

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

THOMSON REUTERS
·
13 Nov 2024

Cyclacel Q3 Basic EPS USD -0.18

THOMSON REUTERS
·
13 Nov 2024

Cyclacel Q3 Operating Expenses USD 2.187 Million

THOMSON REUTERS
·
13 Nov 2024

Cyclacel Pharmaceuticals Inc expected to post a loss of 56 cents a share - Earnings Preview

Reuters
·
08 Nov 2024